Skip to content

GoMobile GO-01

by Monitored Therapeutics, Inc.

GoMobile GO-01 is a pulmonary function analysis software (FDA Class I; FDA product code OUG, Medical Device Data System) made by Monitored Therapeutics, Inc., listed in FDA GUDID since 16 Jul 2026 (UDI-DI 00884400085481), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00884400085481 UDI-DI Date16 Jul 2026ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
GoMobile is a mobile software application intended to support remote patient monitoring and patient self-testing outside of the clinical environment.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
GoMobile
Generic name
Pulmonary function analysis software, non-interpretive
Model / reference
GO-01
Primary DI / UDI-DI
00884400085481
FDA product code
OUG
GMDN term
Pulmonary function analysis software, non-interpretive
Device class
Class I
Regulation number
880.6310
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code OUG (Medical Device Data System).

Other devices from Monitored Therapeutics, Inc.

See all devices from Monitored Therapeutics, Inc. →

Properties

  • Premarket exempt
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)